These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29296522)

  • 1. A library-based screening method identifies neoantigen-reactive T cells in peripheral blood prior to relapse of ovarian cancer.
    Martin SD; Wick DA; Nielsen JS; Little N; Holt RA; Nelson BH
    Oncoimmunology; 2017; 7(1):e1371895. PubMed ID: 29296522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance of the tumor mutanome by T cells during progression from primary to recurrent ovarian cancer.
    Wick DA; Webb JR; Nielsen JS; Martin SD; Kroeger DR; Milne K; Castellarin M; Twumasi-Boateng K; Watson PH; Holt RA; Nelson BH
    Clin Cancer Res; 2014 Mar; 20(5):1125-34. PubMed ID: 24323902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced detection of neoantigen-reactive T cells targeting unique and shared oncogenes for personalized cancer immunotherapy.
    Yossef R; Tran E; Deniger DC; Gros A; Pasetto A; Parkhurst MR; Gartner JJ; Prickett TD; Cafri G; Robbins PF; Rosenberg SA
    JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient identification of neoantigen-specific T-cell responses in advanced human ovarian cancer.
    Liu S; Matsuzaki J; Wei L; Tsuji T; Battaglia S; Hu Q; Cortes E; Wong L; Yan L; Long M; Miliotto A; Bateman NW; Lele SB; Chodon T; Koya RC; Yao S; Zhu Q; Conrads TP; Wang J; Maxwell GL; Lugade AA; Odunsi K
    J Immunother Cancer; 2019 Jun; 7(1):156. PubMed ID: 31221207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of neoantigen-specific T cells and their targets: implications for immunotherapy of head and neck squamous cell carcinoma.
    Ren L; Leisegang M; Deng B; Matsuda T; Kiyotani K; Kato T; Harada M; Park JH; Saloura V; Seiwert T; Vokes E; Agrawal N; Nakamura Y
    Oncoimmunology; 2019; 8(4):e1568813. PubMed ID: 30906664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression.
    Parkhurst M; Gros A; Pasetto A; Prickett T; Crystal JS; Robbins P; Rosenberg SA
    Clin Cancer Res; 2017 May; 23(10):2491-2505. PubMed ID: 27827318
    [No Abstract]   [Full Text] [Related]  

  • 7. Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4.
    van den Bulk J; Verdegaal EME; Ruano D; Ijsselsteijn ME; Visser M; van der Breggen R; Duhen T; van der Ploeg M; de Vries NL; Oosting J; Peeters KCMJ; Weinberg AD; Farina-Sarasqueta A; van der Burg SH; de Miranda NFCC
    Genome Med; 2019 Dec; 11(1):87. PubMed ID: 31888734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients.
    Gros A; Parkhurst MR; Tran E; Pasetto A; Robbins PF; Ilyas S; Prickett TD; Gartner JJ; Crystal JS; Roberts IM; Trebska-McGowan K; Wunderlich JR; Yang JC; Rosenberg SA
    Nat Med; 2016 Apr; 22(4):433-8. PubMed ID: 26901407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors.
    Chen F; Zou Z; Du J; Su S; Shao J; Meng F; Yang J; Xu Q; Ding N; Yang Y; Liu Q; Wang Q; Sun Z; Zhou S; Du S; Wei J; Liu B
    J Clin Invest; 2019 May; 129(5):2056-2070. PubMed ID: 30835255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of T Cell Receptors Targeting a Neoantigen Derived from Recurrently Mutated FGFR3.
    Tate T; Matsumoto S; Nemoto K; Leisegang M; Nagayama S; Obama K; Nakamura Y; Kiyotani K
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of human gastrointestinal cancer neoantigens by circulating PD-1+ lymphocytes.
    Gros A; Tran E; Parkhurst MR; Ilyas S; Pasetto A; Groh EM; Robbins PF; Yossef R; Garcia-Garijo A; Fajardo CA; Prickett TD; Jia L; Gartner JJ; Ray S; Ngo L; Wunderllich JR; Yang JC; Rosenberg SA
    J Clin Invest; 2019 Nov; 129(11):4992-5004. PubMed ID: 31609250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA class I loss in metachronous metastases prevents continuous T cell recognition of mutated neoantigens in a human melanoma model.
    Schrörs B; Lübcke S; Lennerz V; Fatho M; Bicker A; Wölfel C; Derigs P; Hankeln T; Schadendorf D; Paschen A; Wölfel T
    Oncotarget; 2017 Apr; 8(17):28312-28327. PubMed ID: 28423700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of neoantigen-reactive T lymphocytes in the peripheral blood of a patient with glioblastoma.
    Leko V; Cafri G; Yossef R; Paria B; Hill V; Gurusamy D; Zheng Z; Gartner JJ; Prickett TD; Goff SL; Robbins P; Lu YC; Rosenberg SA
    J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34266885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective screening of T cells recognizing neoantigens and construction of T-cell receptor-engineered T cells.
    Kato T; Matsuda T; Ikeda Y; Park JH; Leisegang M; Yoshimura S; Hikichi T; Harada M; Zewde M; Sato S; Hasegawa K; Kiyotani K; Nakamura Y
    Oncotarget; 2018 Feb; 9(13):11009-11019. PubMed ID: 29541393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoantigen Targeting-Dawn of a New Era in Cancer Immunotherapy?
    Wirth TC; Kühnel F
    Front Immunol; 2017; 8():1848. PubMed ID: 29312332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An immunogenic personal neoantigen vaccine for patients with melanoma.
    Ott PA; Hu Z; Keskin DB; Shukla SA; Sun J; Bozym DJ; Zhang W; Luoma A; Giobbie-Hurder A; Peter L; Chen C; Olive O; Carter TA; Li S; Lieb DJ; Eisenhaure T; Gjini E; Stevens J; Lane WJ; Javeri I; Nellaiappan K; Salazar AM; Daley H; Seaman M; Buchbinder EI; Yoon CH; Harden M; Lennon N; Gabriel S; Rodig SJ; Barouch DH; Aster JC; Getz G; Wucherpfennig K; Neuberg D; Ritz J; Lander ES; Fritsch EF; Hacohen N; Wu CJ
    Nature; 2017 Jul; 547(7662):217-221. PubMed ID: 28678778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen Experienced T Cells from Peripheral Blood Recognize p53 Neoantigens.
    Malekzadeh P; Yossef R; Cafri G; Paria BC; Lowery FJ; Jafferji M; Good ML; Sachs A; Copeland AR; Kim SP; Kivitz S; Parkhurst MR; Robbins PF; Ray S; Xi L; Raffeld M; Yu Z; Restifo NP; Somerville RPT; Rosenberg SA; Deniger DC
    Clin Cancer Res; 2020 Mar; 26(6):1267-1276. PubMed ID: 31996390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Ways of Isolating Neoantigen-Specific T Cells.
    Li Q; Ding ZY
    Front Oncol; 2020; 10():1347. PubMed ID: 32850430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro induction of neoantigen-specific T cells in myelodysplastic syndrome, a disease with low mutational burden.
    Ferrari V; Tarke A; Fields H; Ferrari L; Conley T; Ferrari F; Koşaloğlu-Yalçın Z; Sette A; Peters B; McCarthy CL; Bashey A; Tzachanis D; Ball ED; Tanaka TN; Bejar R; Lane TA; Vitiello A
    Cytotherapy; 2021 Apr; 23(4):320-328. PubMed ID: 33262074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stable, Nonviral Expression of Mutated Tumor Neoantigen-specific T-cell Receptors Using the Sleeping Beauty Transposon/Transposase System.
    Deniger DC; Pasetto A; Tran E; Parkhurst MR; Cohen CJ; Robbins PF; Cooper LJ; Rosenberg SA
    Mol Ther; 2016 Jun; 24(6):1078-1089. PubMed ID: 26945006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.